Literature DB >> 5904153

The localization of monoaminergic blood-brain barrier mechanisms.

A Bertler, B Falck, C Owman, E Rosengrenn.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5904153

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  46 in total

Review 1.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

2.  Effects of 5-hydroxytryptamine on pial arteriolar calibre in anaesthetized cats.

Authors:  A M Harper; E T MacKenzie
Journal:  J Physiol       Date:  1977-10       Impact factor: 5.182

Review 3.  Neuronal control of brain microvessel function.

Authors:  H Kobayashi; M S Magnoni; S Govoni; F Izumi; A Wada; M Trabucchi
Journal:  Experientia       Date:  1985-04-15

4.  Presence of norepinephrine and related enzymes in isolated brain microvessels.

Authors:  F M Lai; S Udenfriend; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

5.  Isolated microvessels: the blood-brain barrier in vitro.

Authors:  J T Hjelle; J Baird-Lambert; G Cardinale; S Specor; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

6.  Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.

Authors:  J Constantinidis; J M Gaillard; F Geissbuhler; R Tissot
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

Review 7.  [Biogenic amines in endocrine cells producing polypeptide hormones. The APUD-cells (Pearse) (author's transl)].

Authors:  J Winckler
Journal:  Klin Wochenschr       Date:  1976-01-15

8.  Effect of exogenous noradrenaline on local cerebral blood flow after osmotic opening of the blood-brain barrier in the rat.

Authors:  L Edvinsson; J E Hardebo; E T MacKenzie; C Owman
Journal:  J Physiol       Date:  1978-01       Impact factor: 5.182

9.  Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: studies in rats with complete hypothalamic deafferentations.

Authors:  G A Gudelsky; L Annunziato; K E Moore
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

10.  Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome.

Authors:  C S Wilcox; M J Aminoff
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.